Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment

BACKGROUND: Although precision medicine using genetic information offers significant promise, its uptake and eventual clinical and economic impacts are uncertain. Health care payers will play an important role in evaluating evidence and costs to develop coverage and reimbursement policies. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanda, Devender S., Veenstra, David L., Regier, Dean A., Basu, Anirban, Carlson, Josh J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390910/
https://www.ncbi.nlm.nih.gov/pubmed/32223606
http://dx.doi.org/10.18553/jmcp.2020.26.4.529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390910/
https://www.ncbi.nlm.nih.gov/pubmed/32223606
http://dx.doi.org/10.18553/jmcp.2020.26.4.529

Ejemplares similares